GrippeCanadaV3, Main, Exploration, bibRecord, 000493

Pregnant women's perception of risk with use of the H1N1 vaccine.

Identifieur interne : 000493 ( Main/Exploration ); précédent : 000492; suivant : 000494

Pregnant women's perception of risk with use of the H1N1 vaccine.

Auteurs : Sachi Sakaguchi [Canada] ; Brenda Weitzner [Canada] ; Nathalie Carey [Canada] ; Pina Bozzo [Canada] ; Kamelia Mirdamadi [Canada] ; Nardin Samuel [Canada] ; Gideon Koren [Canada] ; Adrienne Einarson [Canada]

Source :

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC [ 1701-2163 ] ; 2011.

RBID : pubmed:21639966

Descripteurs français

KwdFr :
- Adulte, Adulte d'âge moyen, Canada, Complications de la grossesse et maladies infectieuses (), Complications de la grossesse et maladies infectieuses (psychologie), Connaissances, attitudes et pratiques en santé, Enquêtes et questionnaires, Femelle, Grippe humaine (), Grossesse, Humains, Jeune adulte, Sous-type H1N1 du virus de la grippe A (immunologie), Vaccination (), Vaccination (psychologie), Vaccins antigrippaux (administration et posologie), Éducation du patient comme sujet, Études de cohortes, Études de suivi, Évaluation des risques.
MESH :
- administration et posologie : Vaccins antigrippaux.
- immunologie : Sous-type H1N1 du virus de la grippe A.
- psychologie : Complications de la grossesse et maladies infectieuses, Vaccination.
- Adulte, Adulte d'âge moyen, Canada, Complications de la grossesse et maladies infectieuses, Connaissances, attitudes et pratiques en santé, Enquêtes et questionnaires, Femelle, Grippe humaine, Grossesse, Humains, Jeune adulte, Vaccination, Éducation du patient comme sujet, Études de cohortes, Études de suivi, Évaluation des risques.
Wicri :
- geographic : Canada.

English descriptors

KwdEn :
- Adult, Canada, Cohort Studies, Female, Follow-Up Studies, Health Knowledge, Attitudes, Practice, Humans, Influenza A Virus, H1N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza, Human (prevention & control), Middle Aged, Patient Education as Topic, Pregnancy, Pregnancy Complications, Infectious (prevention & control), Pregnancy Complications, Infectious (psychology), Risk Assessment, Surveys and Questionnaires, Vaccination (psychology), Vaccination (statistics & numerical data), Young Adult.
MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic : Canada.
- immunology : Influenza A Virus, H1N1 Subtype.
- prevention & control : Influenza, Human, Pregnancy Complications, Infectious.
- psychology : Pregnancy Complications, Infectious, Vaccination.
- statistics & numerical data : Vaccination.
- Adult, Cohort Studies, Female, Follow-Up Studies, Health Knowledge, Attitudes, Practice, Humans, Middle Aged, Patient Education as Topic, Pregnancy, Risk Assessment, Surveys and Questionnaires, Young Adult.

Abstract

OBJECTIVE

During the H1N1 influenza pandemic in 2009, The Motherisk Program, a counselling service providing teratology information, received many calls from pregnant women inquiring about the safety of the H1N1 vaccine. We wished to explore pregnant women's perception of risk and the factors associated with deciding whether or not to receive the vaccine.

METHODS

Pregnant women who called Motherisk between October 1 and November 30, 2009, requesting counselling regarding the safety of the H1N1 vaccine, and who had not yet received the vaccine, were contacted for follow-up using a structured questionnaire.

RESULTS

One hundred thirty women completed the questionnaire; 104 (80%) had received the H1N1 vaccination following their call to Motherisk, and 26 (20%) had not. More than 70% of the women cited confusing and frightening information in the media as a trigger for their concern, prompting them to call Motherisk. Sixty percent stated that information from their primary health care providers or Motherisk contributed to their decision making.

CONCLUSION

The H1N1 vaccination rate in pregnant women who contacted Motherisk was higher than the rate in the general population, as many followed Motherisk's recommendation to receive the vaccine. During this period, the media appeared to provide pregnant women with confusing information. In any future pandemic scare, accessibility to primary health care providers or specialized information services such as Motherisk will be key to providing guidance for pregnant women.

DOI: 10.1016/S1701-2163(16)34879-4
PubMed: 21639966

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000526
to stream Main, to step Curation: 000526

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pregnant women's perception of risk with use of the H1N1 vaccine.</title>
<author><name sortKey="Sakaguchi, Sachi" sort="Sakaguchi, Sachi" uniqKey="Sakaguchi S" first="Sachi" last="Sakaguchi">Sachi Sakaguchi</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Weitzner, Brenda" sort="Weitzner, Brenda" uniqKey="Weitzner B" first="Brenda" last="Weitzner">Brenda Weitzner</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Carey, Nathalie" sort="Carey, Nathalie" uniqKey="Carey N" first="Nathalie" last="Carey">Nathalie Carey</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bozzo, Pina" sort="Bozzo, Pina" uniqKey="Bozzo P" first="Pina" last="Bozzo">Pina Bozzo</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mirdamadi, Kamelia" sort="Mirdamadi, Kamelia" uniqKey="Mirdamadi K" first="Kamelia" last="Mirdamadi">Kamelia Mirdamadi</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Samuel, Nardin" sort="Samuel, Nardin" uniqKey="Samuel N" first="Nardin" last="Samuel">Nardin Samuel</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Koren, Gideon" sort="Koren, Gideon" uniqKey="Koren G" first="Gideon" last="Koren">Gideon Koren</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Einarson, Adrienne" sort="Einarson, Adrienne" uniqKey="Einarson A" first="Adrienne" last="Einarson">Adrienne Einarson</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21639966</idno>
<idno type="pmid">21639966</idno>
<idno type="doi">10.1016/S1701-2163(16)34879-4</idno>
<idno type="wicri:Area/Main/Corpus">000526</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000526</idno>
<idno type="wicri:Area/Main/Curation">000526</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000526</idno>
<idno type="wicri:Area/Main/Exploration">000526</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Pregnant women's perception of risk with use of the H1N1 vaccine.</title>
<author><name sortKey="Sakaguchi, Sachi" sort="Sakaguchi, Sachi" uniqKey="Sakaguchi S" first="Sachi" last="Sakaguchi">Sachi Sakaguchi</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Weitzner, Brenda" sort="Weitzner, Brenda" uniqKey="Weitzner B" first="Brenda" last="Weitzner">Brenda Weitzner</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Carey, Nathalie" sort="Carey, Nathalie" uniqKey="Carey N" first="Nathalie" last="Carey">Nathalie Carey</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bozzo, Pina" sort="Bozzo, Pina" uniqKey="Bozzo P" first="Pina" last="Bozzo">Pina Bozzo</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mirdamadi, Kamelia" sort="Mirdamadi, Kamelia" uniqKey="Mirdamadi K" first="Kamelia" last="Mirdamadi">Kamelia Mirdamadi</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Samuel, Nardin" sort="Samuel, Nardin" uniqKey="Samuel N" first="Nardin" last="Samuel">Nardin Samuel</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Koren, Gideon" sort="Koren, Gideon" uniqKey="Koren G" first="Gideon" last="Koren">Gideon Koren</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Einarson, Adrienne" sort="Einarson, Adrienne" uniqKey="Einarson A" first="Adrienne" last="Einarson">Adrienne Einarson</name>
<affiliation wicri:level="4"><nlm:affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC</title>
<idno type="ISSN">1701-2163</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Canada</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Health Knowledge, Attitudes, Practice</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Middle Aged</term>
<term>Patient Education as Topic</term>
<term>Pregnancy</term>
<term>Pregnancy Complications, Infectious (prevention & control)</term>
<term>Pregnancy Complications, Infectious (psychology)</term>
<term>Risk Assessment</term>
<term>Surveys and Questionnaires</term>
<term>Vaccination (psychology)</term>
<term>Vaccination (statistics & numerical data)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Canada</term>
<term>Complications de la grossesse et maladies infectieuses ()</term>
<term>Complications de la grossesse et maladies infectieuses (psychologie)</term>
<term>Connaissances, attitudes et pratiques en santé</term>
<term>Enquêtes et questionnaires</term>
<term>Femelle</term>
<term>Grippe humaine ()</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Vaccination ()</term>
<term>Vaccination (psychologie)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Éducation du patient comme sujet</term>
<term>Études de cohortes</term>
<term>Études de suivi</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Canada</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
<term>Pregnancy Complications, Infectious</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Complications de la grossesse et maladies infectieuses</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Pregnancy Complications, Infectious</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Health Knowledge, Attitudes, Practice</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Patient Education as Topic</term>
<term>Pregnancy</term>
<term>Risk Assessment</term>
<term>Surveys and Questionnaires</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Canada</term>
<term>Complications de la grossesse et maladies infectieuses</term>
<term>Connaissances, attitudes et pratiques en santé</term>
<term>Enquêtes et questionnaires</term>
<term>Femelle</term>
<term>Grippe humaine</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Vaccination</term>
<term>Éducation du patient comme sujet</term>
<term>Études de cohortes</term>
<term>Études de suivi</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b>
</p>
<p>During the H1N1 influenza pandemic in 2009, The Motherisk Program, a counselling service providing teratology information, received many calls from pregnant women inquiring about the safety of the H1N1 vaccine. We wished to explore pregnant women's perception of risk and the factors associated with deciding whether or not to receive the vaccine.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>Pregnant women who called Motherisk between October 1 and November 30, 2009, requesting counselling regarding the safety of the H1N1 vaccine, and who had not yet received the vaccine, were contacted for follow-up using a structured questionnaire.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>One hundred thirty women completed the questionnaire; 104 (80%) had received the H1N1 vaccination following their call to Motherisk, and 26 (20%) had not. More than 70% of the women cited confusing and frightening information in the media as a trigger for their concern, prompting them to call Motherisk. Sixty percent stated that information from their primary health care providers or Motherisk contributed to their decision making.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSION</b>
</p>
<p>The H1N1 vaccination rate in pregnant women who contacted Motherisk was higher than the rate in the general population, as many followed Motherisk's recommendation to receive the vaccine. During this period, the media appeared to provide pregnant women with confusing information. In any future pandemic scare, accessibility to primary health care providers or specialized information services such as Motherisk will be key to providing guidance for pregnant women.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21639966</PMID>
<DateCompleted><Year>2011</Year>
<Month>09</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>09</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1701-2163</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>33</Volume>
<Issue>5</Issue>
<PubDate><Year>2011</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC</Title>
<ISOAbbreviation>J Obstet Gynaecol Can</ISOAbbreviation>
</Journal>
<ArticleTitle>Pregnant women's perception of risk with use of the H1N1 vaccine.</ArticleTitle>
<Pagination><MedlinePgn>460-467</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1701-2163(16)34879-4</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/S1701-2163(16)34879-4</ELocationID>
<Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">During the H1N1 influenza pandemic in 2009, The Motherisk Program, a counselling service providing teratology information, received many calls from pregnant women inquiring about the safety of the H1N1 vaccine. We wished to explore pregnant women's perception of risk and the factors associated with deciding whether or not to receive the vaccine.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Pregnant women who called Motherisk between October 1 and November 30, 2009, requesting counselling regarding the safety of the H1N1 vaccine, and who had not yet received the vaccine, were contacted for follow-up using a structured questionnaire.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred thirty women completed the questionnaire; 104 (80%) had received the H1N1 vaccination following their call to Motherisk, and 26 (20%) had not. More than 70% of the women cited confusing and frightening information in the media as a trigger for their concern, prompting them to call Motherisk. Sixty percent stated that information from their primary health care providers or Motherisk contributed to their decision making.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The H1N1 vaccination rate in pregnant women who contacted Motherisk was higher than the rate in the general population, as many followed Motherisk's recommendation to receive the vaccine. During this period, the media appeared to provide pregnant women with confusing information. In any future pandemic scare, accessibility to primary health care providers or specialized information services such as Motherisk will be key to providing guidance for pregnant women.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sakaguchi</LastName>
<ForeName>Sachi</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Weitzner</LastName>
<ForeName>Brenda</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Carey</LastName>
<ForeName>Nathalie</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bozzo</LastName>
<ForeName>Pina</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mirdamadi</LastName>
<ForeName>Kamelia</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Samuel</LastName>
<ForeName>Nardin</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Koren</LastName>
<ForeName>Gideon</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Einarson</LastName>
<ForeName>Adrienne</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto ON.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>J Obstet Gynaecol Can</MedlineTA>
<NlmUniqueID>101126664</NlmUniqueID>
<ISSNLinking>1701-2163</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010353" MajorTopicYN="Y">Patient Education as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>6</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>6</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">21639966</ArticleId>
<ArticleId IdType="pii">S1701-2163(16)34879-4</ArticleId>
<ArticleId IdType="doi">10.1016/S1701-2163(16)34879-4</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Ontario</li>
</region>
<settlement><li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Ontario"><name sortKey="Sakaguchi, Sachi" sort="Sakaguchi, Sachi" uniqKey="Sakaguchi S" first="Sachi" last="Sakaguchi">Sachi Sakaguchi</name>
</region>
<name sortKey="Bozzo, Pina" sort="Bozzo, Pina" uniqKey="Bozzo P" first="Pina" last="Bozzo">Pina Bozzo</name>
<name sortKey="Carey, Nathalie" sort="Carey, Nathalie" uniqKey="Carey N" first="Nathalie" last="Carey">Nathalie Carey</name>
<name sortKey="Einarson, Adrienne" sort="Einarson, Adrienne" uniqKey="Einarson A" first="Adrienne" last="Einarson">Adrienne Einarson</name>
<name sortKey="Koren, Gideon" sort="Koren, Gideon" uniqKey="Koren G" first="Gideon" last="Koren">Gideon Koren</name>
<name sortKey="Mirdamadi, Kamelia" sort="Mirdamadi, Kamelia" uniqKey="Mirdamadi K" first="Kamelia" last="Mirdamadi">Kamelia Mirdamadi</name>
<name sortKey="Samuel, Nardin" sort="Samuel, Nardin" uniqKey="Samuel N" first="Nardin" last="Samuel">Nardin Samuel</name>
<name sortKey="Weitzner, Brenda" sort="Weitzner, Brenda" uniqKey="Weitzner B" first="Brenda" last="Weitzner">Brenda Weitzner</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000493 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000493 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21639966
   |texte=   Pregnant women's perception of risk with use of the H1N1 vaccine.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21639966" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020

	Corpus GrippeCanadaV3
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus GrippeCanadaV3

Pregnant women's perception of risk with use of the H1N1 vaccine.

Pregnant women's perception of risk with use of the H1N1 vaccine.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki